The kingdom is committed to staying at the forefront of scientific advancements and integrating them into treatment and rehabilitation services for Bahrainis, His Royal Highness Prince Salman bin Hamad Al Khalifa, Crown Prince and Prime Minister, said yesterday.
This is a top priority, he said during a visit to the world’s first sickle cell disease patient outside the United States to successfully complete treatment with Casgevy (exagamglogene autotemcel), a CRISPR-based gene-editing therapy using bone marrow transplantation technology – at the Bone Marrow and Stem Cell Transplant Unit at the Royal Medical Services-Bahrain Oncology Centre .
&uuid=(email))